Transient elastography predicts survival after radiofrequency ablation of hepatocellular carcinoma developing on cirrhosis. Issue 1 (31st July 2019)
- Record Type:
- Journal Article
- Title:
- Transient elastography predicts survival after radiofrequency ablation of hepatocellular carcinoma developing on cirrhosis. Issue 1 (31st July 2019)
- Main Title:
- Transient elastography predicts survival after radiofrequency ablation of hepatocellular carcinoma developing on cirrhosis
- Authors:
- Rekik, Samia
Allaire, Manon
Mumana, Annie
Guyot, Erwan
Nkontchou, Gisèle
Grando, Véronique
Blaise, Lorraine
Ziol, Marianne
Nahon, Pierre
Ganne‐Carrié, Nathalie
Sutter, Olivier
Seror, Olivier
Nault, Jean‐Charles - Abstract:
- Abstract: Background and aim: The prognostic value of transient elastography (TE) in cirrhotic patients with hepatocellular carcinoma (HCC) treated by percutaneous radiofrequency ablation (RFA) is currently unknown. Method(s): We included patients with histologically proven cirrhosis and with a first diagnosis of HCC inside Milan criteria treated by percutaneous RFA, and with TE available the year before treatment with 10 shots and interquartile range/median < 30%. Association between variables and clinical events was assessed by the Kaplan–Meier method with the log–rank test and using Cox univariate and multivariate analyses. Results: One hundred fifty‐nine patients were included, with a median age of 65 years; 77.4% were men. Causes of cirrhosis were alcohol consumption (48.1%), hepatitis C (43.7%), hepatitis B (12.7%), and non‐alcoholic steatohepatitis (32.3%). Median value of TE was 26 kPa (4–75 kPa). Overall survival at 1, 2, and 5 years was, respectively, 93%, 81%, and 44%; overall recurrence was 28%, 49%, and 80%. The TE value was not associated with tumor recurrence (0.13). In contrast, in univariate analysis, TE value, age, Child–Pugh B, and alkaline phosphatase were predictive factors in overall survival. In multivariate analysis, TE value (hazards ratio [HR] = 1.02, 95% confidence interval (IC): 1.01–1.04, 0.001), age (HR = 1.05, 95% IC: 1.03–1.08, P = 0.00006), and Child–Pugh B score (HR = 2.78, 95% IC: 1.27–6.08, P = 0.01) were independently associated withAbstract: Background and aim: The prognostic value of transient elastography (TE) in cirrhotic patients with hepatocellular carcinoma (HCC) treated by percutaneous radiofrequency ablation (RFA) is currently unknown. Method(s): We included patients with histologically proven cirrhosis and with a first diagnosis of HCC inside Milan criteria treated by percutaneous RFA, and with TE available the year before treatment with 10 shots and interquartile range/median < 30%. Association between variables and clinical events was assessed by the Kaplan–Meier method with the log–rank test and using Cox univariate and multivariate analyses. Results: One hundred fifty‐nine patients were included, with a median age of 65 years; 77.4% were men. Causes of cirrhosis were alcohol consumption (48.1%), hepatitis C (43.7%), hepatitis B (12.7%), and non‐alcoholic steatohepatitis (32.3%). Median value of TE was 26 kPa (4–75 kPa). Overall survival at 1, 2, and 5 years was, respectively, 93%, 81%, and 44%; overall recurrence was 28%, 49%, and 80%. The TE value was not associated with tumor recurrence (0.13). In contrast, in univariate analysis, TE value, age, Child–Pugh B, and alkaline phosphatase were predictive factors in overall survival. In multivariate analysis, TE value (hazards ratio [HR] = 1.02, 95% confidence interval (IC): 1.01–1.04, 0.001), age (HR = 1.05, 95% IC: 1.03–1.08, P = 0.00006), and Child–Pugh B score (HR = 2.78, 95% IC: 1.27–6.08, P = 0.01) were independently associated with higher risk of death. A TE value ≥ 40 kPa was associated with shorter median overall survival (34 months) compared to a TE value < 40 kPa (59 months, P = 0.0008). Conclusion(s): Transient elastography (TE) predicts overall survival but not tumor recurrence in cirrhotic patients with HCC treated by RFA. … (more)
- Is Part Of:
- Journal of gastroenterology and hepatology. Volume 35:Issue 1(2020)
- Journal:
- Journal of gastroenterology and hepatology
- Issue:
- Volume 35:Issue 1(2020)
- Issue Display:
- Volume 35, Issue 1 (2020)
- Year:
- 2020
- Volume:
- 35
- Issue:
- 1
- Issue Sort Value:
- 2020-0035-0001-0000
- Page Start:
- 142
- Page End:
- 150
- Publication Date:
- 2019-07-31
- Subjects:
- carcinogenesis and metastasis -- clinical -- hepatocellar carcinoma -- hepatocellular carcinoma -- treatment
Gastroenterology -- Periodicals
Digestive organs -- Diseases -- Periodicals
Liver -- Diseases -- Periodicals
Gastroenterology -- Periodicals
Liver Diseases -- Periodicals
616.33 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1440-1746 ↗
http://onlinelibrary.wiley.com/ ↗
http://www.blackwell-synergy.com/loi/jgh ↗ - DOI:
- 10.1111/jgh.14763 ↗
- Languages:
- English
- ISSNs:
- 0815-9319
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4987.615000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 12610.xml